Analyze Diet

Equine muscular dystrophy with myotonia.

Abstract: To describe a case of equine muscular dystrophy with myotonia. Methods: A 5-year-old horse presented with hypertrophy and delayed relaxation of the muscles of the hindlimbs from age 2 months. Testicular atrophy developed from 2 years of age. Action and percussion myotonia was associated with weakness in these muscles, and EMG showed diffuse myotonic discharges and myopathic features. Biopsy of the gluteal muscle showed adipose and connective tissue infiltration, marked variation in muscle fibre size, and moth-eaten, ring and whorled fibres. Results: Injection of apamin, a peptide blocker of calcium-activated potassium channels, which inhibits myotonia in human myotonic dystrophy, was ineffective in blocking myotonic discharges. Discharges promptly abated with 2% lidocaine injection. Conclusions: Myotonia in this horse is associated with dystrophic changes similar to human myotonic dystrophy, though there are some pharmacological differences.
Publication Date: 2001-02-13 PubMed ID: 11165532DOI: 10.1016/s1388-2457(00)00511-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research describes a case of equine muscular dystrophy with myotonia, a rare condition in horses, including its symptoms, the outcomes of treatment attempts, and its parallels to the human version of the disease.

Introduction and Methods

  • This study focuses on a specific case of a 5-year-old horse that has been experiencing symptoms of hypertrophy (excessive growth or enlargement) and delayed muscle relaxation in its hindlimbs since it was 2 months old. Additionally, from the age of about 2 years, the horse also began showing signs of testicular atrophy.
  • The researchers carried out action and percussion myotonia tests, which detected weakness in the affected muscles. In humans, myotonia refers to an issue where muscles cannot relax properly after contracting. Electromyography (EMG) was also performed, revealing diffuse myotonic discharges and myopathic features – both indicators of unusual nerve and muscle activity.
  • A biopsy from the horse’s gluteal muscle was taken for analysis. This revealed adipose and connective tissue infiltration, significant variation in muscle fibre size, and specific damage patterns such as moth-eaten, ring, and whorled fibers, which are common signs of muscular dystrophy.

Results

  • The researchers attempted to block the myotonic discharges in the muscles using apamin, a substance that blocks calcium-activated potassium channels in humans suffering from myotonic dystrophy. This attempt proved unsuccessful.
  • An immediate change was, however, observed when 2% lidocaine, a local anesthetic, was injected. The myotonic discharges ceased quite promptly.

Conclusions

  • The researchers concluded that the myotonia observed in this case was indeed associated with dystrophic changes, similar to those seen in cases of human myotonic dystrophy.
  • Despite the similar symptoms and progression, there are pharmacological differences between equine and human versions of myotonic dystrophy, as suggested by the different treatment responses. These distinctions require further exploration and may contribute to a better understanding of the disease in both species.

Cite This Article

APA
Montagna P, Liguori R, Monari L, Strong PN, Riva R, Di Stasi V, Gandini G, Cipone M. (2001). Equine muscular dystrophy with myotonia. Clin Neurophysiol, 112(2), 294-299. https://doi.org/10.1016/s1388-2457(00)00511-3

Publication

ISSN: 1388-2457
NlmUniqueID: 100883319
Country: Netherlands
Language: English
Volume: 112
Issue: 2
Pages: 294-299

Researcher Affiliations

Montagna, P
  • Institute of Clinical Neurology, University of Bologna Medical School, Via U. Foscolo 7, 40123, Bologna, Italy. pmontagn@neuro.unibo.it
Liguori, R
    Monari, L
      Strong, P N
        Riva, R
          Di Stasi, V
            Gandini, G
              Cipone, M

                MeSH Terms

                • Anesthetics, Local / therapeutic use
                • Animals
                • Apamin / therapeutic use
                • Atrophy
                • Electromyography
                • Hindlimb
                • Horse Diseases / drug therapy
                • Horse Diseases / pathology
                • Horse Diseases / physiopathology
                • Horses
                • Hypertrophy
                • Lidocaine / therapeutic use
                • Male
                • Muscle Relaxation
                • Muscle Weakness / etiology
                • Muscle, Skeletal / drug effects
                • Muscle, Skeletal / pathology
                • Muscle, Skeletal / physiopathology
                • Muscular Dystrophy, Animal / complications
                • Muscular Dystrophy, Animal / drug therapy
                • Muscular Dystrophy, Animal / pathology
                • Muscular Dystrophy, Animal / physiopathology
                • Myotonia / complications
                • Myotonia / drug therapy
                • Myotonia / physiopathology
                • Myotonia / veterinary
                • Neural Conduction
                • Testis / pathology
                • Treatment Failure

                Citations

                This article has been cited 4 times.